Company performance
Add to research
Current Price
as of Feb 13, 2025$64.37
P/E Ratio
15.15
Market Cap
$1.99B
Description
Add to research
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.
Metrics
Add to research
Overview
- HQLargo, FL
- SectorHealth Technology
- IndustryMedical Specialties
- TickerCNMD
- Price$64.37+2.99%
Trading Information
- Market cap$1.99B
- Float97.20%
- Average Daily Volume (1m)537,527
- Average Daily Volume (3m)434,333
- EPS$4.29
Company
- Revenue$1.31B
- Rev growth (1yr)5.32%
- Net income$132.42M
- Gross margin56.21%
- EBITDA margin18.24%
- EBITDA$238.45M
- EVN/A
- EV/RevenueN/A
- P/E15.15
- P/S1.53
- P/B2.13
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset